JPWO2021224901A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021224901A5
JPWO2021224901A5 JP2024509421A JP2024509421A JPWO2021224901A5 JP WO2021224901 A5 JPWO2021224901 A5 JP WO2021224901A5 JP 2024509421 A JP2024509421 A JP 2024509421A JP 2024509421 A JP2024509421 A JP 2024509421A JP WO2021224901 A5 JPWO2021224901 A5 JP WO2021224901A5
Authority
JP
Japan
Prior art keywords
formulation
cyclosporine
weight
stable
nanomicelle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024509421A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024530244A (ja
JP2024530244A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2021/059176 external-priority patent/WO2021224901A2/en
Publication of JP2024530244A publication Critical patent/JP2024530244A/ja
Publication of JPWO2021224901A5 publication Critical patent/JPWO2021224901A5/ja
Publication of JP2024530244A5 publication Critical patent/JP2024530244A5/ja
Pending legal-status Critical Current

Links

JP2024509421A 2021-08-20 2021-10-06 安定なシクロスポリン眼科用製剤及びその製造プロセス Pending JP2024530244A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN202121037917 2021-08-20
IN202121037917 2021-08-20
PCT/IB2021/059176 WO2021224901A2 (en) 2021-08-20 2021-10-06 Stable cyclosporine ophthalmic formulation and manufacturing process thereof

Publications (3)

Publication Number Publication Date
JP2024530244A JP2024530244A (ja) 2024-08-16
JPWO2021224901A5 true JPWO2021224901A5 (https=) 2024-10-16
JP2024530244A5 JP2024530244A5 (https=) 2024-10-16

Family

ID=78468801

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024509421A Pending JP2024530244A (ja) 2021-08-20 2021-10-06 安定なシクロスポリン眼科用製剤及びその製造プロセス
JP2024509422A Pending JP2024530245A (ja) 2021-08-20 2022-08-22 安定なシクロスポリン眼科用製剤及びその製造プロセス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024509422A Pending JP2024530245A (ja) 2021-08-20 2022-08-22 安定なシクロスポリン眼科用製剤及びその製造プロセス

Country Status (8)

Country Link
US (2) US20240342086A1 (https=)
EP (2) EP4387589A4 (https=)
JP (2) JP2024530244A (https=)
CN (2) CN117957011A (https=)
AU (2) AU2021267217A1 (https=)
IL (2) IL310823A (https=)
MX (2) MX2024002234A (https=)
WO (2) WO2021224901A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4719350A1 (en) * 2023-05-29 2026-04-08 Sun Pharmaceutical Industries Limited Stable cyclosporine ophthalmic formulation and manufacturing process thereof
WO2025163677A1 (en) * 2024-01-31 2025-08-07 Registrar, Panjab University, Chandigarh Nanomicellar composition for high permeation and extended-release drug delivery system

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2836946C (en) * 2011-05-27 2017-08-01 Allergan, Inc. A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof
PL2887923T3 (pl) * 2012-08-24 2023-08-14 Sun Pharmaceutical Industries Limited Preparat okulistyczny polioksylipidu lub polioksylowego kwasu tłuszczowego i leczenie chorób oczu
US20200237859A1 (en) * 2019-01-25 2020-07-30 Newport Research, Inc. Aqueous suspensions of cyclosporin
EP3373976B1 (en) * 2015-11-10 2024-01-03 Sun Pharmaceutical Industries Limited Topical formulations and uses thereof
US10918694B2 (en) * 2016-02-29 2021-02-16 Sun Pharma Global Fze Topical cyclosporine-containing formulations and uses thereof

Similar Documents

Publication Publication Date Title
KR910007511A (ko) 콜라겐 함유 안약 제형
JPWO2021224901A5 (https=)
CN1322131A (zh) 含尼美舒利的局部药用组合物
IL310887A (en) Stable cyclosporine ophthalmic formulation and its manufacturing process
CN110665430A (zh) 一种耐酸型绿色皮克林乳化剂的制备方法及其皮克林乳化剂
JPH0390024A (ja) 眼疾患を処置するための5―メチル―イソオキサゾール―4―カルボン酸アニリド類または2―ヒドロキシエチリデン―シアノ酢酸アニリド類含有医薬組成物
JP2002524410A (ja) リプスタチン誘導体−可溶性繊維錠剤
JPWO2023021492A5 (https=)
US4602040A (en) Meclofenamic acid topical pharmaceutical composition
JP2002284673A (ja) 生理学的に許容可能な水溶液の調製法およびこの方法により得られた溶液
JP5500162B2 (ja) 点眼剤
JP4294276B2 (ja) 点眼剤組成物
CN111358758A (zh) 一种盐酸溴己新分散片及其制备方法
CN116850140A (zh) 一种注射用氨苄西林钠舒巴坦钠药物组合物及其制备方法
CN1218689C (zh) 包含妥布霉素和黄原胶的药物组合物
US20110053877A1 (en) Nimesulide and muscle relaxant combinations thereof
RU2409346C2 (ru) Водный гель для местного применения высокой стабильности на основе метронидазола и способ его получения
CN117089084A (zh) 一种新型水凝胶的制备方法
CN111803464A (zh) 一种塞来昔布胶囊制剂
US20060270708A1 (en) Novel process for preparation of isotonic aqueous injection of ropivacaine
JP4961671B2 (ja) 点眼剤
JPH02164829A (ja) ヒアルロン酸点眼液
JP4779382B2 (ja) 点眼剤用組成物
JP2002518348A5 (https=)
JP2005239658A (ja) 点眼剤